Based on my searches, I can see that while there are papers on longitudinal biomarker analysis and predictive modeling, the specific search terms for "predictive health risk scoring from longitudinal lab data" with the exact phrasing you're looking for didn't yield many results. However, I found several relevant papers and can provide evidence-based findings based on the available research. Let me synthesize what I found:

# Evidence-Based Findings: Predictive Health Risk Scoring from Longitudinal Lab Data

## **Current Research Landscape (2019-2026)**

### **1. Key Algorithms and Methodologies**

**Deep Recurrent Models for Longitudinal Prediction** (Jung et al., 2020, NeuroImage):
- **Architecture**: Deep recurrent networks that jointly handle:
  - Missing value imputation in time series data
  - Phenotypic measurements forecasting
  - Trajectory estimation of clinical scores
  - Clinical status prediction
- **Performance**: Demonstrated on Alzheimer's disease progression using longitudinal MRI biomarkers
- **Implementation Insight**: End-to-end training with carefully defined loss functions

**Transformer-Based Time-Series Frameworks** (Yang et al., 2025, Precision Clinical Medicine):
- **Application**: ICU risk stratification with daily risk alerts
- **Performance**: Progressive AUC increase from 0.87 (day 1) to 0.92 (day 5)
- **Key Feature**: Temporal heatmaps using SHAP for interpretable biomarker dynamics
- **Architecture**: Two-stage design capturing evolving health trajectories

**Joint Modeling Approaches** (Dong et al., 2021, Journal of Applied Statistics):
- **Method**: Functional principal component analysis for jointly modeling multiple transplant outcomes
- **Application**: Kidney function monitoring via glomerular filtration rate (GFR) trajectories
- **Advantage**: More accurate predictions than separate longitudinal and survival models

### **2. Temporal Pattern Mining Techniques**

**Biomarker Trajectory Analysis** (Multiple studies, 2019-2023):
- **Neurofilament Light Chain**: Predicts clinical progression and death in multiple system atrophy (Chelban et al., 2022)
- **Plasma Biomarkers**: Longitudinal analysis of extracellular vesicles for Alzheimer's prediction (Kapogiannis et al., 2019)
- **Time to Positivity**: Model-based biomarker analysis for tuberculosis treatment response (Gewitz et al., 2021)

**Change-Point Detection Approaches** (Implicit in reviewed literature):
- **Statistical Methods**: Comparing approaches for assessing prognostic effects of biomarker variability (Gao et al., 2022)
- **Machine Learning**: Identification of complicated sepsis courses using longitudinal gene expression (Banerjee et al., 2021)

### **3. Early Warning Systems Implementation**

**ICU Predictive Systems** (Yang et al., 2025):
- **Real-time Identification**: High-risk patient detection with actionable insights
- **External Validation**: 81.8% accuracy on Chinese sepsis data, 76.56% on MIMIC-IV
- **Clinical Integration**: Bridges model predictions with interpretable biomarkers

**Digital Twin Technology** (Shamanna et al., 2022, European Heart Journal):
- **Whole-Body Digital Twin Platform**: AI-powered precision nutrition with continuous glucose monitoring
- **Outcome**: Demonstrated T2D remission and cardiovascular risk reduction
- **Approach**: Technology-enabled precision nutrition combining macro, micro, and biota nutrients

## **Implementation Framework for Your Stack**

### **Architecture Recommendations**

**1. Data Pipeline (Compatible with Supabase + Next.js):**
```
Raw Lab Data → OCR Parsing → Biomarker Extraction → Time Series Storage
     ↓
Embedding Generation (Alibaba DashScope text-embedding-v4)
     ↓
Vector Storage (pgvector for 1024-dim embeddings)
     ↓
Temporal Pattern Mining
```

**2. Algorithm Selection Matrix:**

| **Algorithm Type** | **Complexity** | **pgvector Compatibility** | **Use Case** |
|-------------------|---------------|----------------------------|--------------|
| **Sliding Window Statistics** | Low | High | Basic trend detection |
| **Exponential Smoothing** | Medium | High | Short-term forecasting |
| **ARIMA Models** | Medium | Medium | Seasonal patterns |
| **LSTM/GRU Networks** | High | Low (requires ML runtime) | Complex trajectories |
| **Transformer Models** | Very High | Low | Multi-biomarker interactions |

**3. Practical Implementation Strategy:**

**Phase 1: Foundation (Implementable Now)**
- **Trend Detection**: Simple linear regression on biomarker trajectories
- **Risk Scoring**: Weighted combination of:
  - Current value deviation from personal baseline
  - Rate of change (slope)
  - Acceleration (second derivative)
  - Distance to clinical thresholds

**Phase 2: Advanced (Requires ML Integration)**
- **Personalized Baselines**: Dynamic baseline calculation using moving percentiles
- **Anomaly Detection**: Statistical process control charts for each biomarker
- **Multi-biomarker Integration**: Correlation-based risk aggregation

### **4. Specific Feature Implementation**

**HbA1c Trend Prediction (Your Example):**
```sql
-- Supabase/pgvector compatible approach
WITH hba1c_trajectories AS (
  SELECT 
    patient_id,
    test_date,
    hba1c_value,
    -- Calculate personal baseline (30-day moving average)
    AVG(hba1c_value) OVER (
      PARTITION BY patient_id 
      ORDER BY test_date 
      ROWS BETWEEN 30 PRECEDING AND CURRENT ROW
    ) as personal_baseline,
    -- Calculate trend (linear regression slope)
    REGR_SLOPE(hba1c_value, 
      EXTRACT(EPOCH FROM test_date)) OVER (
        PARTITION BY patient_id 
        ORDER BY test_date 
        ROWS BETWEEN 5 PRECEDING AND CURRENT ROW
    ) as trend_slope
  FROM lab_results
  WHERE biomarker = 'HbA1c'
)
SELECT 
  patient_id,
  test_date,
  hba1c_value,
  personal_baseline,
  trend_slope,
  -- Risk score calculation
  CASE 
    WHEN hba1c_value >= 6.5 THEN 'Diabetes - Immediate Concern'
    WHEN hba1c_value >= 5.7 AND trend_slope > 0.1 THEN 'Pre-diabetes - Rapid Progression'
    WHEN hba1c_value >= 5.7 AND trend_slope <= 0.1 THEN 'Pre-diabetes - Stable'
    WHEN hba1c_value < 5.7 AND trend_slope > 0.05 THEN 'Normal - Concerning Trend'
    ELSE 'Normal - Stable'
  END as risk_category
FROM hba1c_trajectories;
```

**5. Early Warning System Architecture:**

```
Component Stack:
1. Data Ingestion Layer (Next.js Server Actions)
   - Lab report upload and OCR parsing
   - Biomarker extraction and validation

2. Temporal Analysis Engine (PostgreSQL + pgvector)
   - Time series storage with vector embeddings
   - Real-time trend calculations
   - Pattern matching against known risk trajectories

3. Risk Scoring Module (SQL + Python UDFs)
   - Personalized baseline computation
   - Multi-biomarker risk aggregation
   - Threshold-based alert generation

4. Visualization & Alerting (Next.js + shadcn/ui)
   - Interactive trend dashboards
   - Real-time risk notifications
   - Clinical decision support
```

## **Evidence-Based Recommendations**

### **1. Start with Simple, Interpretable Models**
- **Rationale**: Clinical adoption requires interpretability
- **Evidence**: Gao et al. (2022) compared statistical methods for biomarker variability assessment
- **Implementation**: Begin with statistical process control and linear trend analysis

### **2. Focus on Missing Data Handling**
- **Rationale**: Longitudinal clinical data has inherent missingness
- **Evidence**: Jung et al. (2020) explicitly addressed missing value imputation
- **Implementation**: Implement multiple imputation strategies in your pipeline

### **3. Prioritize Clinical Validation**
- **Rationale**: Predictive accuracy must translate to clinical utility
- **Evidence**: Yang et al. (2025) demonstrated external validation across diverse cohorts
- **Implementation**: Establish validation framework with clinical outcomes

### **4. Leverage Existing Infrastructure**
- **Rationale**: Your stack supports vector-based similarity search
- **Implementation**: Use pgvector for:
  - Similar trajectory pattern matching
  - Risk profile clustering
  - Historical case retrieval for decision support

## **Research Gaps Identified**

1. **Limited Papers on Personal Health Dashboards**: Despite growing interest, few published implementations of personal health analytics platforms with predictive scoring
2. **Sparse Literature on Change-Point Detection**: While mentioned conceptually, few papers detail specific change-point algorithms for clinical biomarkers
3. **Implementation-Focused Research**: Most papers focus on algorithm development rather than system architecture

## **Conclusion**

The research supports implementing predictive health risk scoring from longitudinal lab data using your existing stack. Key findings:

1. **Algorithm Selection**: Start with interpretable statistical models (trend analysis, control charts) before advancing to deep learning
2. **Architecture Compatibility**: Your stack (pgvector, embeddings, Next.js) supports the core requirements
3. **Implementation Pathway**: Phased approach from simple trend detection to complex trajectory prediction
4. **Clinical Integration**: Focus on interpretability and validation for clinical utility

The most promising direction combines the temporal modeling approaches from ICU predictive systems (Yang et al., 2025) with the personalized trajectory analysis from neurodegenerative disease research (Jung et al., 2020), adapted for preventive health monitoring in your personal health analytics platform.